Literature DB >> 33094395

Does hand involvement in systemic sclerosis limit completion of patient-reported outcome measures?

Tracy M Frech1, John M VanBuren2, Emily Startup2, Shervin Assassi3, Elana J Bernstein4, Flavia V Castelino5, Lorinda Chung6, Chase Correia7, Jessica K Gordon8, Faye N Hant9, Laura Hummers10, Dinesh Khanna11, Nora Sandorfi12, Ami A Shah10, Victoria K Shanmugam13, Virginia Steen14, Luke Evnin15.   

Abstract

The objective of this analysis is to examine whether the severity of systemic sclerosis (SSc)-hand involvement influences patient-reported outcome measure (PROM) completion rate in a US cohort of early disease. Participants included SSc patients with less than 5 years disease duration consented and enrolled in the Collaborative, National, Quality, and Efficacy Registry (CONQUER) between June 2018 and December 2019. Participants' socio-demographics, hand clinical features (severe modified Rodnan skin score, presence of small joint contractures, acro-osteolysis, calcinosis, and digital ulcers), and completion rates of seven PROMs including a Resource Use Questionnaire were analyzed. Cohort characteristics and baseline PROM completion were evaluated. Multivariable logistic regression assessed the relationship between hand limitations and PROM incompletion at several time points using generalized estimating equations. At the time of data lock, 339 CONQUER subjects had a total of 600 visits available for analysis. Calcinosis (odds ratio [OR] 6.35, confidence interval [CI] 2.41-16.73 and acro-osteolysis OR 3.88 (1.57-9.55) were significantly associated with incomplete PROM. The Resource Use Questionnaire was the PROM most commonly not completed. Increasing age was correlated with resource use questionnaire incompletion rate. Acro-osteolysis and calcinosis were associated with lower PROM completion rates in a US SSc cohort, independent of the length of the questionnaires or the modality of administration (electronic or paper). Resource Use Questionnaires are important for understanding the economic impact and burden of chronic disease; however, in this study, it had lower completion rates than PROMs devoted to clinical variables. Key points •Multiple strategies are needed to ensure optimal completion of PROM in longitudinal cohort studies. Even if patients request electronic surveys, we have found it is important to follow up incomplete surveys with paper forms provided at the time of a clinical visit. •The Resource Utilization Questionnaire was lengthy and prone to non-completion in the younger population. •Acro-osteolysis and calcinosis were associated with reduced PROM completion rates.

Entities:  

Keywords:  Disability; Patient reported outcomes measures; Systemic sclerosis

Mesh:

Year:  2020        PMID: 33094395      PMCID: PMC7897231          DOI: 10.1007/s10067-020-05467-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  13 in total

1.  Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosis.

Authors:  Monique E Hinchcliff; Jennifer L Beaumont; Mary A Carns; Sofia Podlusky; Krishna Thavarajah; John Varga; David Cella; Rowland W Chang
Journal:  J Rheumatol       Date:  2014-11-01       Impact factor: 4.666

2.  Hand Impairment in Systemic Sclerosis: Various Manifestations and Currently Available Treatment.

Authors:  Amber Young; Rajaie Namas; Carole Dodge; Dinesh Khanna
Journal:  Curr Treatm Opt Rheumatol       Date:  2016-07-19

3.  SYSTEMIC SCLEROSIS RELATED CALCINOSIS: PATIENTS PROVIDE WHAT SPECIALISTS WANT TO LEARN.

Authors:  A Christensen; S Khalique; S Cenac; K Fligelstone; A Mawdsley; T French; J K Gordon; M Baron; E Busman; V D Steen; L A Saketkoo
Journal:  J La State Med Soc       Date:  2015-06-15

Review 4.  Musculoskeletal hand involvement in systemic sclerosis.

Authors:  Robert David Sandler; Marco Matucci-Cerinic; Michael Hughes
Journal:  Semin Arthritis Rheum       Date:  2019-11-09       Impact factor: 5.532

5.  Patient-reported outcome instrument selection: designing a measurement strategy.

Authors:  Claire F Snyder; Maria E Watson; Joseph D Jackson; David Cella; Michele Y Halyard
Journal:  Value Health       Date:  2007 Nov-Dec       Impact factor: 5.725

Review 6.  Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), physician- and patient-rated global assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler's Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud's Condition Score (RCS).

Authors:  Janet Pope
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

7.  Collaborative National Quality and Efficacy Registry (CONQUER) for Scleroderma: outcomes from a multicenter US-based systemic sclerosis registry.

Authors:  Victoria K Shanmugam; Tracy M Frech; Virginia D Steen; Laura K Hummers; Ami A Shah; Elana J Bernstein; Dinesh Khanna; Jessica K Gordon; Flavia V Castelino; Lorinda Chung; Faye N Hant; Emily Startup; John M VanBuren; Luke B Evnin; Shervin Assassi
Journal:  Clin Rheumatol       Date:  2019-10-30       Impact factor: 2.980

8.  Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.

Authors: 
Journal:  Health Qual Life Outcomes       Date:  2006-10-11       Impact factor: 3.186

Review 9.  Patient reported outcome measures in rare diseases: a narrative review.

Authors:  Anita Slade; Fatima Isa; Derek Kyte; Tanya Pankhurst; Larissa Kerecuk; James Ferguson; Graham Lipkin; Melanie Calvert
Journal:  Orphanet J Rare Dis       Date:  2018-04-23       Impact factor: 4.123

10.  Psychometric validation of the Hand Disability in Systemic Sclerosis-Digital Ulcers (HDISS-DU®) patient-reported outcome instrument.

Authors:  Luc Mouthon; Serge Poiraudeau; Margaret Vernon; Kelly Papadakis; Loïc Perchenet; Dinesh Khanna
Journal:  Arthritis Res Ther       Date:  2020-01-06       Impact factor: 5.156

View more
  2 in total

Review 1.  Calcinosis in systemic sclerosis.

Authors:  Srijana Davuluri; Christian Lood; Lorinda Chung
Journal:  Curr Opin Rheumatol       Date:  2022-08-19       Impact factor: 4.941

2.  Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United States.

Authors:  Elana J Bernstein; Shervin Assassi; Flavia V Castelino; Lorinda Chung; Chase Correia; Luke B Evnin; Tracy M Frech; Jessica K Gordon; Brian A Skaug; Faye N Hant; Laura K Hummers; Nora Sandorfi; Ami A Shah; Victoria K Shanmugam; Virginia D Steen; Dinesh Khanna
Journal:  ACR Open Rheumatol       Date:  2022-04-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.